Loading...

LPTX LEAP THERAPEUTICS INC Delisting Actions 8-K Filing

LP T

LPTX

LEAP THERAPEUTICS INC

(LPTX)

2025 8-K

Show Summary

Show Summary

Financial Statements

Financial Results

Nasdaq Notification

Clinical Data Release

Financial Results

Study Enrollment Complete

Financial Results

Annual Meeting Results

Financial Results Announcement

Private Placement Agreement

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

Annual Meeting of Stockholders

Reverse Stock Split

Financial Results Announcement

Amendment to Employment Agr...

Financial Results Announcement

Agreement Expiration and Co...

Acquisition of Flame Biosci...

External Links:

On March 12, 2025, Leap Therapeutics, Inc. received a notice from Nasdaq stating that its stock price has been below the required $1.00 for 30 consecutive days, giving it until September 8, 2025, to regain compliance.

AI Assistant

LEAP THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.